Alan W Dunton insider trades

Open-market stock purchases and sales by Alan W Dunton, Director at CorMedix Inc, from SEC Form 4 filings since Jun 11, 2010.

Track record: 67% of 6 scored buys are up 5% or more since purchase, averaging +60%.

Recent trades

DateStockTradeValue
Jan 26, 2026CRMD CorMedix IncBought (not open market)—
Dec 30, 2025CRMD CorMedix IncBought (not open market)—
Dec 30, 2025CRMD CorMedix IncSold$260K
Dec 11, 2025OGEN Oragenics IncBought (not open market)—
Dec 9, 2025PTN Palatin Technologies IncBought (not open market)—
Dec 9, 2025PTN Palatin Technologies IncBought (not open market)—

Companies traded

  • CRMD CorMedix Inc: 4 buys, 2 sales, last Jan 26, 2026
  • OGEN Oragenics Inc: 1 buy, 26 sales, last Dec 11, 2025
  • PTN Palatin Technologies Inc: 14 buys, 4 sales, last Dec 9, 2025
  • OGEN.BC Oragenics Inc: other filings, last Jun 22, 2017
  • TRGT Targacept Inc: 4 sales, last Aug 14, 2015
  • EPCT Epicept Corp: other filings, last Aug 12, 2013
  • ORNI Oragenics Inc: other filings, last Aug 6, 2012
  • MNOV Medicinova Inc: other filings, last Jun 11, 2010

Get free alerts when Alan W Dunton files a new trade →